TAIPEI, 17 février 2025 /PRNewswire/ — TAHO Pharmaceuticals annonce des résultats préliminaires positifs de l’étude pivot de TAH3311, le premier film à dissolution orale (ODF) d’Apixaban au monde. L’étude a confirmé que TAH3311 est bioéquivalent aux comprimés d’apixaban (Eliquis®) de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.